106 related articles for article (PubMed ID: 16339531)
1. Quantifying the contribution of defective ribosomal products to antigen production: a model-based computational analysis.
Bulik S; Peters B; Holzhütter HG
J Immunol; 2005 Dec; 175(12):7957-64. PubMed ID: 16339531
[TBL] [Abstract][Full Text] [Related]
2. Re-examining class-I presentation and the DRiP hypothesis.
Rock KL; Farfán-Arribas DJ; Colbert JD; Goldberg AL
Trends Immunol; 2014 Apr; 35(4):144-52. PubMed ID: 24566257
[TBL] [Abstract][Full Text] [Related]
3. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
Yewdell JW; Antón LC; Bennink JR
J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
[TBL] [Abstract][Full Text] [Related]
4. The DRiP hypothesis decennial: support, controversy, refinement and extension.
Yewdell JW; Nicchitta CV
Trends Immunol; 2006 Aug; 27(8):368-73. PubMed ID: 16815756
[TBL] [Abstract][Full Text] [Related]
5. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.
Yewdell JW
Trends Immunol; 2011 Nov; 32(11):548-58. PubMed ID: 21962745
[TBL] [Abstract][Full Text] [Related]
6. Targeting HIV-1 Gag into the defective ribosomal product pathway enhances MHC class I antigen presentation and CD8+ T cell activation.
Goldwich A; Hahn SS; Schreiber S; Meier S; Kämpgen E; Wagner R; Lutz MB; Schubert U
J Immunol; 2008 Jan; 180(1):372-82. PubMed ID: 18097038
[TBL] [Abstract][Full Text] [Related]
7. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.
Dolan BP; Bennink JR; Yewdell JW
Cell Mol Life Sci; 2011 May; 68(9):1481-9. PubMed ID: 21416150
[TBL] [Abstract][Full Text] [Related]
8. Positional bias of MHC class I restricted T-cell epitopes in viral antigens is likely due to a bias in conservation.
Kim Y; Yewdell JW; Sette A; Peters B
PLoS Comput Biol; 2013; 9(1):e1002884. PubMed ID: 23357871
[TBL] [Abstract][Full Text] [Related]
9. Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation.
Wenger T; Terawaki S; Camosseto V; Abdelrassoul R; Mies A; Catalan N; Claudio N; Clavarino G; de Gassart A; Rigotti Fde A; Gatti E; Pierre P
Autophagy; 2012 Mar; 8(3):350-63. PubMed ID: 22377621
[TBL] [Abstract][Full Text] [Related]
10. The synthesis of truncated polypeptides for immune surveillance and viral evasion.
Cardinaud S; Starck SR; Chandra P; Shastri N
PLoS One; 2010 Jan; 5(1):e8692. PubMed ID: 20098683
[TBL] [Abstract][Full Text] [Related]
11. Rethinking peptide supply to MHC class I molecules.
Eisenlohr LC; Huang L; Golovina TN
Nat Rev Immunol; 2007 May; 7(5):403-10. PubMed ID: 17457346
[TBL] [Abstract][Full Text] [Related]
12. The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation.
Hahn S; Setz C; Wild J; Schubert U
J Immunol; 2011 May; 186(10):5706-18. PubMed ID: 21482733
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.
Strehl B; Seifert U; Krüger E; Heink S; Kuckelkorn U; Kloetzel PM
Immunol Rev; 2005 Oct; 207():19-30. PubMed ID: 16181324
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.
Palmer AL; de Jong A; Leestemaker Y; Geurink PP; Wijdeven RH; Ovaa H; Dolan BP
J Immunol; 2018 Feb; 200(3):928-936. PubMed ID: 29282303
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Interferons on Presentation of Defective Ribosomal Products as HLA Peptides.
Komov L; Melamed Kadosh D; Barnea E; Admon A
Mol Cell Proteomics; 2021; 20():100105. PubMed ID: 34087483
[TBL] [Abstract][Full Text] [Related]
16. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.
Voo KS; Fu T; Wang HY; Tellam J; Heslop HE; Brenner MK; Rooney CM; Wang RF
J Exp Med; 2004 Feb; 199(4):459-70. PubMed ID: 14769850
[TBL] [Abstract][Full Text] [Related]
18. The nature and extent of contributions by defective ribosome products to the HLA peptidome.
Bourdetsky D; Schmelzer CE; Admon A
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1591-9. PubMed ID: 24715725
[TBL] [Abstract][Full Text] [Related]
19. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.
Schubert U; Antón LC; Gibbs J; Norbury CC; Yewdell JW; Bennink JR
Nature; 2000 Apr; 404(6779):770-4. PubMed ID: 10783891
[TBL] [Abstract][Full Text] [Related]
20. Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool.
Fiebiger BM; Moosmann A; Behrends U; Mautner J
Eur J Immunol; 2012 Dec; 42(12):3167-73. PubMed ID: 22944914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
